Paysign, Inc. (PAYS) closed the last trading session at $5.49, gaining 7.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $9.1 indicates a 65.8% upside potential.The mean estimate comprises five short-term price targets with a standard deviation of $0.65. While the lowest estimate of $8.50 indicates a 54.8% increase from the current price level, the most optimistic analyst expect ...

Group 1 - Alliance Entertainment Holding Corporation (AENT) shares have increased by 14.1% over the past four weeks, closing at $7.6, with a mean price target of $9.67 indicating a potential upside of 27.2% [1] - The average price targets range from a low of $8.00 to a high of $11.00, with a standard deviation of $1.53, suggesting a potential increase of 5.3% to 44.7% from the current price level [2] - Analysts show strong agreement in revising earnings estimates higher, which historically correlates with positive stock price movements [11][12] Group 2 - AENT has a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13] - The Zacks Consensus Estimate for the current year has increased by 3.6% over the last 30 days, with no negative revisions, further supporting the positive outlook for the stock [12] - While price targets may not be entirely reliable, the direction they imply appears to be a good guide for potential price movement [14]

LiveRamp (RAMP) closed the last trading session at $30.3, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $42.14 indicates a 39.1% upside potential.The mean estimate comprises seven short-term price targets with a standard deviation of $7.8. While the lowest estimate of $33.00 indicates an 8.9% increase from the current price level, the most optimistic analyst expects ...

Core Viewpoint - Life Time Group Holdings, Inc. (LTH) has shown a 1.7% increase in share price over the past four weeks, closing at $25.9, with analysts suggesting a potential upside of 54.1% based on a mean price target of $39.91 [1]. Price Targets - The average price target consists of 11 estimates ranging from a low of $33.00 to a high of $45.00, with a standard deviation of $3.96, indicating a potential increase of 27.4% to 73.8% from the current price [2]. - A low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement, which can be a useful starting point for further research [9]. Analyst Sentiment - Analysts are optimistic about LTH's earnings prospects, as indicated by a consensus in revising earnings per share (EPS) estimates higher, which has historically correlated with stock price movements [11]. - Over the past 30 days, one estimate has increased while there have been no negative revisions, leading to a 1.6% increase in the Zacks Consensus Estimate for the current year [12]. Zacks Rank - LTH holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a strong potential for upside in the near term [13]. Conclusion on Price Targets - While the consensus price target may not be a reliable measure of the extent of LTH's potential gains, the implied direction of price movement appears to be a useful guide for investors [14].

Royal Caribbean (RCL) shares rallied 7.4% in the last trading session to close at $279.7. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 1.2% loss over the past four weeks.Shares of Royal Caribbean climbed after the company declared a $1.00 quarterly dividend payable Jan. 14, 2026, to shareholders of record on Dec. 26, 2025, and authorized a $2 billion stock buyback program.This cruise operator is expected t ...

Shares of PepGen, Inc. (PEPG) have gained 22.6% over the past four weeks to close the last trading session at $5.7, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $10 indicates a potential upside of 75.4%.The mean estimate comprises six short-term price targets with a standard deviation of $5.83. While the lowest estimate of $3.00 indicates a 47.4% decline from the current pric ...

Group 1 - Archer Aviation Inc. (ACHR) closed at $8.95, with a 0.8% gain over the past four weeks, and a mean price target of $11.61 suggests a 29.7% upside potential [1] - The average of nine short-term price targets ranges from a low of $4.50 to a high of $18.00, with a standard deviation of $3.86, indicating variability in analyst estimates [2] - Analysts have shown increasing optimism regarding ACHR's earnings prospects, with a strong agreement in revising EPS estimates higher, which correlates with potential stock price movements [11][12] Group 2 - The Zacks Consensus Estimate for the current year has increased by 7.2% over the past month, with three estimates going higher and no negative revisions [12] - ACHR holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating potential upside [13] - While the consensus price target may not be a reliable indicator of the extent of gains, it does provide a directional guide for price movement [14]

Core Viewpoint - Jade Biosciences, Inc. (JBIO) shares have increased by 25% in the last four weeks, closing at $12, with a potential upside indicated by Wall Street analysts' price targets suggesting a mean estimate of $19.8, representing a 65% upside [1][11]. Price Targets and Analyst Consensus - The average price target for JBIO ranges from a low of $16.00 to a high of $28.00, with a standard deviation of $4.76, indicating a potential increase of 33.3% to 133.3% from the current price [2][11]. - A low standard deviation among price targets suggests a strong agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9][10]. Earnings Estimates and Analyst Optimism - Analysts have shown increasing optimism about JBIO's earnings prospects, as evidenced by a positive trend in earnings estimate revisions, which correlates strongly with near-term stock price movements [4][11]. - The Zacks Consensus Estimate for the current year has risen by 14.2% over the past month, with two estimates increasing and no negative revisions [12][13]. Zacks Rank and Investment Potential - JBIO holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside in the near term [13][14].

Core Viewpoint - Driven Brands Holdings Inc. (DRVN) shows potential for significant upside, with a mean price target of $21.31 indicating a 45.9% increase from the current price of $14.61 [1] Price Targets and Analyst Estimates - The mean estimate consists of 13 short-term price targets, with a standard deviation of $2.1, indicating variability among analysts [2] - The lowest estimate is $18.00, suggesting a 23.2% increase, while the highest estimate is $25.00, indicating a potential surge of 71.1% [2] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement [9] Earnings Estimates and Analyst Sentiment - Analysts are optimistic about DRVN's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which correlates with near-term stock price movements [11] - Over the last 30 days, six earnings estimates have been revised upward, leading to a 5.4% increase in the Zacks Consensus Estimate [12] - DRVN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are a common tool for investors, they can often mislead, and reliance solely on them may lead to poor investment decisions [3][7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]

Core Viewpoint - IHS Holding (IHS) shows potential for significant upside, with a mean price target of $9.63 indicating a 40.2% increase from its current price of $6.87 [1] Price Targets - The average price target consists of eight estimates ranging from a low of $6.00 to a high of $17.00, with a standard deviation of $3.51, indicating variability among analysts [2] - The lowest estimate suggests a decline of 12.7%, while the highest indicates a potential upside of 147.5% [2] - A low standard deviation suggests a higher agreement among analysts regarding price movement [9] Analyst Sentiment - Analysts are optimistic about IHS's earnings prospects, with a consensus indicating better-than-previously estimated earnings [4][11] - Over the past 30 days, one estimate has increased, leading to a 105.3% rise in the Zacks Consensus Estimate for the current year [12] Zacks Rank - IHS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - Solely relying on price targets for investment decisions may not be wise, as they can often mislead investors [3][7][10] - Analysts may set overly optimistic targets due to business incentives, which can inflate price expectations [8]